89 related articles for article (PubMed ID: 31880080)
1. Active Targeting of Dendritic Polyglycerols for Diagnostic Cancer Imaging.
Pant K; Neuber C; Zarschler K; Wodtke J; Meister S; Haag R; Pietzsch J; Stephan H
Small; 2020 Feb; 16(7):e1905013. PubMed ID: 31880080
[TBL] [Abstract][Full Text] [Related]
2. The influence of surface charge on serum protein interaction and cellular uptake: studies with dendritic polyglycerols and dendritic polyglycerol-coated gold nanoparticles.
Bewersdorff T; Vonnemann J; Kanik A; Haag R; Haase A
Int J Nanomedicine; 2017; 12():2001-2019. PubMed ID: 28352171
[TBL] [Abstract][Full Text] [Related]
3. ⁹⁹mTc-labeled single-domain antibody EG2 in targeting epidermal growth factor receptor: an in-vitro and mouse model in-vivo study.
Li C; Wen B; Wang L; Feng H; Xia X; Ding Z; Gao B; Zhang Y; Lan X
Nucl Med Commun; 2015 May; 36(5):452-60. PubMed ID: 25591074
[TBL] [Abstract][Full Text] [Related]
4. PET Imaging of Macrophage Mannose Receptor-Expressing Macrophages in Tumor Stroma Using 18F-Radiolabeled Camelid Single-Domain Antibody Fragments.
Blykers A; Schoonooghe S; Xavier C; D'hoe K; Laoui D; D'Huyvetter M; Vaneycken I; Cleeren F; Bormans G; Heemskerk J; Raes G; De Baetselier P; Lahoutte T; Devoogdt N; Van Ginderachter JA; Caveliers V
J Nucl Med; 2015 Aug; 56(8):1265-71. PubMed ID: 26069306
[TBL] [Abstract][Full Text] [Related]
5. Fluorine-18 Labeling of the HER2-Targeting Single-Domain Antibody 2Rs15d Using a Residualizing Label and Preclinical Evaluation.
Zhou Z; Vaidyanathan G; McDougald D; Kang CM; Balyasnikova I; Devoogdt N; Ta AN; McNaughton BR; Zalutsky MR
Mol Imaging Biol; 2017 Dec; 19(6):867-877. PubMed ID: 28409338
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic nanoparticle targeting of the EGF-receptor in complex biological conditions using single-domain antibodies.
Zarschler K; Prapainop K; Mahon E; Rocks L; Bramini M; Kelly PM; Stephan H; Dawson KA
Nanoscale; 2014 Jun; 6(11):6046-56. PubMed ID: 24777583
[TBL] [Abstract][Full Text] [Related]
7. Zwitterionic near-infrared fluorophore-conjugated epidermal growth factor for fast, real-time, and target-cell-specific cancer imaging.
Kim H; Cho MH; Choi HS; Lee BI; Choi Y
Theranostics; 2019; 9(4):1085-1095. PubMed ID: 30867817
[TBL] [Abstract][Full Text] [Related]
8. Engineering the Orientation, Density, and Flexibility of Single-Domain Antibodies on Nanoparticles To Improve Cell Targeting.
Yong KW; Yuen D; Chen MZ; Johnston APR
ACS Appl Mater Interfaces; 2020 Feb; 12(5):5593-5600. PubMed ID: 31917547
[TBL] [Abstract][Full Text] [Related]
9. Highly Uniform Synthesis of Selenium Nanoparticles with EGFR Targeting and Tumor Microenvironment-Responsive Ability for Simultaneous Diagnosis and Therapy of Nasopharyngeal Carcinoma.
Huang J; Huang W; Zhang Z; Lin X; Lin H; Peng L; Chen T
ACS Appl Mater Interfaces; 2019 Mar; 11(12):11177-11193. PubMed ID: 30821437
[TBL] [Abstract][Full Text] [Related]
10. Tuning nanoparticle uptake: live-cell imaging reveals two distinct endocytosis mechanisms mediated by natural and artificial EGFR targeting ligand.
Mickler FM; Möckl L; Ruthardt N; Ogris M; Wagner E; Bräuchle C
Nano Lett; 2012 Jul; 12(7):3417-23. PubMed ID: 22632479
[TBL] [Abstract][Full Text] [Related]
11. Surface charge and particle size determine the metabolic fate of dendritic polyglycerols.
Pant K; Pufe J; Zarschler K; Bergmann R; Steinbach J; Reimann S; Haag R; Pietzsch J; Stephan H
Nanoscale; 2017 Jun; 9(25):8723-8739. PubMed ID: 28616954
[TBL] [Abstract][Full Text] [Related]
12. Iron oxide nanoparticles stabilized with dendritic polyglycerols as selective MRI contrast agents.
Nordmeyer D; Stumpf P; Gröger D; Hofmann A; Enders S; Riese SB; Dernedde J; Taupitz M; Rauch U; Haag R; Rühl E; Graf C
Nanoscale; 2014 Aug; 6(16):9646-54. PubMed ID: 24991655
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of [64Cu]Cu-NOTA-Bn-GE11 for PET imaging of EGFR-rich tumors.
Dejesus OT
Curr Radiopharm; 2012 Jan; 5(1):15-8. PubMed ID: 21864245
[TBL] [Abstract][Full Text] [Related]
14. (99m) Tc-labeled tetramer and pentamer of single-domain antibody for targeting epidermal growth factor receptor in xenografted tumors.
Li C; Feng H; Xia X; Wang L; Gao B; Zhang Y; Lan X
J Labelled Comp Radiopharm; 2016 Jun; 59(8):305-12. PubMed ID: 27123559
[TBL] [Abstract][Full Text] [Related]
15. In vivo evaluation of cetuximab-conjugated poly(γ-glutamic acid)-docetaxel nanomedicines in EGFR-overexpressing gastric cancer xenografts.
Sreeranganathan M; Uthaman S; Sarmento B; Mohan CG; Park IK; Jayakumar R
Int J Nanomedicine; 2017; 12():7165-7182. PubMed ID: 29033568
[TBL] [Abstract][Full Text] [Related]
16. Cy5.5-labeled Affibody molecule for near-infrared fluorescent optical imaging of epidermal growth factor receptor positive tumors.
Miao Z; Ren G; Liu H; Jiang L; Cheng Z
J Biomed Opt; 2010; 15(3):036007. PubMed ID: 20615009
[TBL] [Abstract][Full Text] [Related]
17. Pointing in the Right Direction: Controlling the Orientation of Proteins on Nanoparticles Improves Targeting Efficiency.
Yong KW; Yuen D; Chen MZ; Porter CJH; Johnston APR
Nano Lett; 2019 Mar; 19(3):1827-1831. PubMed ID: 30773887
[TBL] [Abstract][Full Text] [Related]
18. Targeting EGFR of triple-negative breast cancer enhances the therapeutic efficacy of paclitaxel- and cetuximab-conjugated nanodiamond nanocomposite.
Liao WS; Ho Y; Lin YW; Naveen Raj E; Liu KK; Chen C; Zhou XZ; Lu KP; Chao JI
Acta Biomater; 2019 Mar; 86():395-405. PubMed ID: 30660004
[TBL] [Abstract][Full Text] [Related]
19. Active targeting theranostic iron oxide nanoparticles for MRI and magnetic resonance-guided focused ultrasound ablation of lung cancer.
Wang Z; Qiao R; Tang N; Lu Z; Wang H; Zhang Z; Xue X; Huang Z; Zhang S; Zhang G; Li Y
Biomaterials; 2017 May; 127():25-35. PubMed ID: 28279919
[TBL] [Abstract][Full Text] [Related]
20. Improving the targeting of therapeutics with single-domain antibodies.
Turner KB; Alves NJ; Medintz IL; Walper SA
Expert Opin Drug Deliv; 2016; 13(4):561-70. PubMed ID: 26689649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]